Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Cerence Sees Q4 Sales $53.000M-$58.000M vs $57.454M Est

Author: Benzinga Newsdesk | August 06, 2025 03:08pm
Cerence (NASDAQ:CRNC) sees Q4 sales of $53.000 million-$58.000 million vs $57.454 million analyst estimate.

Posted In: CRNC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist